Slow recruitment due to Covid-19 disruptions continues to climb
There has been an increase in trials impacted by slow recruitment due to the Covid-19 pandemic, despite the fall of disrupted trials.
Operations
Service planning in Europe would benefit from complete registration of NMSCs
All cases of BCC, a type of NMSC, should be reported for better treatment planning...
Impact of underdiagnosis of plaque psoriasis in Black and Hispanic Americans
Underdiagnosed plaque psoriasis in Black and Hispanic Americans can severely impact their quality of life...
The effect of the Covid-19 pandemic on the Tokyo Olympic Games
There are warnings that having millions of spectators at the Olympic Games in Tokyo will...
Long-acting drugs to shake up GHD in 3MM
The fast uptake of long-acting growth hormones (GH) is predicted to transform the hormone deficiency...
Dealing with the unexpected: Covid-19 and risk management
Major global events such as the ongoing Covid-19 pandemic can cause significant problems for clinical trials and pharma research programmes. Oncoinvent head of clinical operations Helén Johansen Blanco shares her expertise on proactive risk management...
Worldwide selects ClinSpark eSource platform to automate trials
Worldwide Clinical Trials has implemented Foundry Health’s ClinSpark eSource Platform to automate Phase I first-in-human clinical trials for clinical development.
Signant Health offers eConsent support for oncology trial in UK
Clinical trial solutions provider Signant Health has agreed to provide electronic informed consent (eConsent) support for an oncology trial by the University of Bristol in the UK.
VirTrial enables virtual trials at Pratia site network
Clinical trials technology provider VirTrial has formed an alliance to enable virtual clinical trials at Pratia clinical research centres in Europe.
Parexel signs data technology deal with Datavant
Biopharmaceutical services provider Parexel has entered a multi-year collaboration with healthcare data services firm Datavant to link real-world data across clinical trials.
Survey finds downward trend in use of eClinical technologies
A new global survey commissioned by Oracle Health Sciences has found that investigational sites are facing challenges in adopting eClinical technologies due to disjointed techniques and complexity.
